Technology Offerings

Innovative Methods to Inhibit IL-4 and IL-13 Signaling

The current patent application deals with the inhibition of signalling through the cytokines IL-4 and IL-13. Pathologically increased activation of this signaling cascade is associated with asthma, atopic dermatitis and related diseases.

Further Information: PDF

GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120

Contact
Beate-Victoria Ermisch

Comments (0)

Write a comment